Goldman Sachs Group Inc Frequency Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$0.35 - $0.72 $74,228 - $152,699	212,082 New	212,082 $78,000
Q3 2023 Nov 14, 2023	BUY	$0.35 - $0.72 $74,228 - $152,699	212,082 New	212,082 $78,000
Q4 2022 May 14, 2024	SELL	$1.88 - $3.85 $24,515 - $50,204	-13,040 Reduced 23.3%	42,925 $165,000
Q4 2022 Feb 13, 2023	SELL	$1.88 - $3.85 $24,515 - $50,204	-13,040 Reduced 23.3%	42,925 $165,000
Q3 2022 May 14, 2024	SELL	$1.46 - $2.55 $29,331 - $51,229	-20,090 Reduced 26.42%	55,965 $100,000
Q3 2022 Nov 10, 2022	SELL	$1.46 - $2.55 $29,331 - $51,229	-20,090 Reduced 26.42%	55,965 $0
Q2 2022 May 14, 2024	BUY	$1.03 - $2.03 $78,336 - $154,391	76,055 New	76,055 $114,000
Q2 2022 Aug 15, 2022	SELL	$1.03 - $2.03 $90,076 - $177,529	-87,453 Reduced 53.49%	76,055 $114,000
Q1 2022 May 16, 2022	BUY	$1.7 - $5.72 $40,949 - $137,783	24,088 Added 17.28%	163,508 $346,000
Q4 2021 Feb 14, 2022	BUY	$4.95 - $7.11 $18,453 - $26,506	3,728 Added 2.75%	139,420 $715,000
Q3 2021 Nov 10, 2021	BUY	$6.96 - $9.25 $944,416 - $1.26 Million	135,692 New	135,692 $958,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.